Bixlenvo Sunlenca Starter Pack Kit
Product Images NDC 61958-3701

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bixlenvo Sunlenca Starter Pack (NDC 61958-3701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bictegravir Structure)

Chemical structure of lenacapavir sodium, showing its molecular framework with distinctive functional groups and fluorinated aromatic rings.*

FDA Label Image

Chemical Structure (Lenacapavir Structure)

Chemical structure of the active ingredients in Bixlenvo Sunlenca Starter Pack, representing bictegravir and lenacapavir sodium molecules, showing atomic composition and bonds including fluorine, nitrogen, chlorine, trifluoromethyl, sulfone, and sodium components.*

FDA Label Image

Bixlenvo/sunlenca Starter Pack Kit Carton (Bixlenvo Sunlenca Starter Pack 01)

Bixlenvo Sunlenca Starter Pack kit includes bictegravir and lenacapavir tablets with strengths of 75 mg/50 mg and lenacapavir tablets at 300 mg. The packaging shows it contains 1 bottle of 30 Bixlenvo tablets and 1 bottle of 4 Sunlenca tablets. Manufactured by Gilead Sciences, Inc., the label lists storage instructions and manufacturer details for both products.*

FDA Label Image

Bixlenvo-starter Pack-02 (Bixlenvo Starter Pack 02)

Label for Sunlenca (lenacapavir) tablets, 300 mg per tablet, in a package of 4 tablets. The label includes storage instructions (20°C to 25°C), a warning to keep out of reach of children, and directions to talk to a healthcare provider before use. Manufactured for Gilead Sciences, Inc., Foster City, CA, and made in Canada.*

FDA Label Image

Sunlenca-starter Pack-03 (Sunlenca Starter Pack 03)

Label for Bixlenvo tablets containing bictegravir and lenacapavir, 75 mg/50 mg strength, in a package of 30 tablets. The label indicates storage instructions, manufacturer as Gilead Sciences, Inc., and notes the product is Rx only and not for individual sale. Product NDC 61958-3601-3 is printed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.